Natural controlled HIV infection: preserved HIV-specific immunity despite undetectable replication competent virus.
Long-term non-progressive HIV infection, characterized by low but detectable viral load and stable CD4 counts in the absence of antiviral therapy, is observed in about 5% of HIV-infected patients. Here we identified four therapy naïve individuals who are strongly seropositive for HIV-1 but who lack evidence of detectable HIV p24 antigen, plasma RNA, and proviral DNA in routine diagnostic testing. With an ultrasensitive PCR, we established that frequencies of pol proviral DNA sequences were as low as 0.2-0.5 copies/10(6) PBMC. HIV could not be isolated using up to 30x10(6) patient PBMC. One individual was heterozygous for CCR5 Delta32, but CCR5 expression on CD4+ T cells was normal to high in all four individuals. In vitro R5 and X4 HIV-1 susceptibility of CD8-depleted PBMC of all study subjects was significantly lower than the susceptibility of CD8-depleted PBMC of healthy blood donors. All individuals expressed protective HLA-B*58s alleles and showed evidence of HIV-specific cellular immunity either by staining with HLA-B*57 tetramers folded with an HIV RT or gag peptide or after stimulation with HIV-1 p24 gag, RT, or nef peptides in ELIspot analysis. HIV-specific CD4+ T helper cells were demonstrated by proliferation of CD4+ T cells and intracellular staining for IL-2 and IFNgamma after stimulation with an HIV-gag peptide pool. Sera of all individuals showed antibody-mediated neutralization of both R5 and X4 HIV-1 variants. These data implicate that very low-level antigen exposure is sufficient for sustained HIV-specific immunity and suggest the possibility of a multi-factorial control of HIV infection.
Kloosterboer
Nico
N
Sanquin Research at CLB, Landsteiner Laboratory at the Academic Medical Center, Department of Clinical Viro Immunology, Plesmanlaan 125, University of Amsterdam, 1066 CX Amsterdam, The Netherlands.
Groeneveld
Paul H P
PH
Jansen
Christine A
CA
van der Vorst
Teun J K
TJ
Koning
Fransje
F
Winkel
Carel N
CN
Duits
Ashley J
AJ
Miedema
Frank
F
van Baarle
Debbie
D
van Rij
Ronald P
RP
Brinkman
Kees
K
Schuitemaker
Hanneke
H
D000328:Adult; D000483:Alleles; D018791:CD4 Lymphocyte Count; D005260:Female; D015483:HIV Antibodies / Q000276:immunology; D016655:HIV Core Protein p24 / Q000097:blood; D006679:HIV Seropositivity / Q000235:genetics / Q000276:immunology* / Q000821:virology; D015497:HIV-1 / Q000235:genetics; D015235:HLA-B Antigens / Q000235:genetics; D006579:Heterozygote; D006801:Humans; D007963:Leukocytes, Mononuclear / Q000821:virology; D008297:Male; D008875:Middle Aged; D009500:Neutralization Tests; D011533:Proviruses / Q000235:genetics; D019713:Receptors, CCR5 / Q000235:genetics / Q000378:metabolism; D006377:T-Lymphocytes, Helper-Inducer / Q000276:immunology
D015483:HIV Antibodies; D016655:HIV Core Protein p24; D015235:HLA-B Antigens; D019713:Receptors, CCR5